✦ LIBER ✦

Comparison of a homologous series of benzonaphthyridine anti-cancer agents in mice: divergence between tumour and plasma pharmacokinetics

✍ Scribed by Lukka, Pradeep B.; Paxton, James W.; Kestell, Philip; Baguley, Bruce C.

Book ID: 113028112
Publisher: Springer
Year: 2012
Tongue: English
Weight: 313 KB
Volume: 70
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-012-1892-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis and plasma pharmacokinetics in

Synthesis and plasma pharmacokinetics in CD-1 mice of a 18β-glycyrrhetinic acid derivative displaying anti-cancer activity

✍ Lallemand, Benjamin; Ouedraogo, Moustapha; Wauthoz, Nathalie; Lamkami, Touria; M 📂 Article 📅 2012 🏛 Pharmaceutical Press 🌐 English ⚖ 555 KB

Simultaneous determination of the novel

Simultaneous determination of the novel thiosemicarbazone anti-cancer agent, Bp4eT, and its main phase I metabolites in plasma: Application to a pilot pharmacokinetic study in rats

✍ Stariat, Ján; Suprunová, Vlasta; Roh, Jaroslav; Šesták, Vít; Eisner, Tomáš; Fili 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB

Investigation of 5-FU disposition after

Investigation of 5-FU disposition after oral administration of capecitabine, a triple-prodrug of 5-FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: comparison of the simulated 5-FU exposures in the tumour tissue between human and xenograft model

✍ Yuko Tsukamoto; Yukio Kato; Masako Ura; Ikuo Horii; Tohru Ishikawa; Hideo Ishits 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 2 views

## Abstract The nonlinear pharmacokinetics of capecitabine, a triple prodrug of 5‐FU preferentially activated in tumour tissues, was investigated in human cancer xenograft models. A physiologically based pharmacokinetic (PBPK) model integrating the activation process of capecitabine to 5‐FU and 5‐F